R
Roger Stupp
Researcher at Northwestern University
Publications - 463
Citations - 73077
Roger Stupp is an academic researcher from Northwestern University. The author has contributed to research in topics: Temozolomide & Glioma. The author has an hindex of 93, co-authored 430 publications receiving 63025 citations. Previous affiliations of Roger Stupp include Merck & Co. & University of St. Gallen.
Papers
More filters
Journal ArticleDOI
Clinical management and outcome of histologically verified adult brainstem gliomas in Switzerland: a retrospective analysis of 21 patients
Thomas Hundsberger,Michaela Tonder,Andreas F. Hottinger,Detlef Brügge,Ulrich Roelcke,Paul Martin Putora,Roger Stupp,Michael Weller +7 more
TL;DR: Histologically verification of adult BSGs is feasible and has an impact on postoperative treatment, and Radiochemotherapy with temozolomide can safely be prescribed for high-grade gliomas without additional CNS toxicities.
Journal ArticleDOI
Does cilengitide deserve another chance?-Authors' reply.
Journal ArticleDOI
A prospective, randomized, open-label, phase III clinical trial of NovoTTF-100A versus best standard of care chemotherapy in patients with recurrent glioblastoma.
Roger Stupp,Andrew A. Kanner,Herbert H. Engelhard,V. Heidecke,S. Taillibert,Frank S. Lieberman,V. Dbaly,Eilon D. Kirson,Yoram Palti,Philip H. Gutin +9 more
TL;DR: NovoTTF is a portable, medical device delivering low intensity, intermediate frequency, alternating electric fields by means of noninvasive, disposable scalp electrodes as mentioned in this paper, which physically interfere with cell division and assembly of organelles.
Journal ArticleDOI
Phase II study of docetaxel in the treatment of patients with advanced non-small cell lung cancer in routine daily practice.
Karin Mattson,Lionel Bosquée,G Dabouis,A. Le Groumellec,J.L. Pujol,S Marien,Roger Stupp,Jean-Yves Douillard,B Brägas,J Berille,R Olivares,T. Le Chevalier +11 more
TL;DR: It was possible to confirm the efficacy of docetaxel as a single agent for first- and second-line chemotherapy in a large patient population treated in a community setting.
Journal ArticleDOI
Ribosomal protein S11 influences glioma response to TOP2 poisons.
Chidiebere U. Awah,Li Chen,Mukesh Bansal,Aayushi Mahajan,Jan Winter,Meeki Lad,Louisa Warnke,Edgar Gonzalez-Buendia,Cheol Park,Daniel Zhang,Eric Feldstein,Dou Yu,Markella Zannikou,Irina V. Balyasnikova,Regina T. Martuscello,Silvana Konerman,Balázs Győrffy,Balázs Győrffy,Kirsten Bell Burdett,Denise M. Scholtens,Roger Stupp,Atique Ahmed,Patrick D. Hsu,Adam M. Sonabend +23 more
TL;DR: To identify genes that confer susceptibility to this drug in gliomas, a genome-scale CRISPR knockout screen with etoposide identified ribosomal protein subunit RPS11, 16, and 18 as putative biomarkers for response to TOP2 poisons.